Navigation Links
Hologic to Host Investor Presentation at RSNA 2013
Date:11/5/2013

BEDFORD, Mass., Nov. 5, 2013 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products, with an emphasis on serving the healthcare needs of women, today announced the Company will host presentations for members of the investment community at the the 99th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) in Chicago, Illinois. For more information about RSNA, please visit RSNA 2013.

Hologic's investor meeting will be held on Tuesday, December 3, 2013, at McCormick Place from 8:00 a.m. to 10:00 a.m. (Central Time) and will include presentations by members of Hologic's management team.

Interested participants are invited to listen to a live audio webcast of Hologic's presentation on the investor relations page of the Company's website at www.hologic.com/investor-overview. Additional call information also will be provided on the investor relations website closer to the event date. An archive of the presentation will be available for replay following the event.

About Hologic, Inc.:Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems, and surgical products, with an emphasis on serving the healthcare needs of women. The Company operates four core business units focused on breast health, diagnostics, GYN surgical and skeletal health. With a comprehensive suite of technologies and a robust research and development program, Hologic is committed to improving lives. The Company is headquartered in Massachusetts. For more information, visit www.hologic.com.

Hologic and associated logos are trademarks and/or registered trademarks of Hologic, Inc. and/or its subsidiaries in the United States and/or other countries. Contacts:Deborah R. Gordon

Al KildaniVice President, Investor Relations

Senior Director, Investor Relations (781) 999-7716

(858) 410-8653deborah.gordon@hologic.com

al.kildani@hologic.com


'/>"/>
SOURCE Hologic, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Hologic to Mark Start of Breast Cancer Awareness Month with NASDAQ Opening Bell Ceremony
2. Hologic to Present at Two Upcoming Investor Conferences
3. Hologic Announces Third Quarter Fiscal 2013 Operating Results
4. Hologic Announces Completion of Term Loan B Repricing
5. FDA Clears Hologics Single Energy Femur Exam to Visualize Features Associated with Developing Atypical Femur Fractures on a DXA Platform
6. FDA APPROVES APTIMA HPV ASSAY FOR USE ON HOLOGICS PANTHER SYSTEM
7. Hologic Appoints Jack W. Cumming President and Chief Executive Officer
8. Commercial Release of 3D (Breast Tomosynthesis) Biopsy Option Strengthens Hologics Position as Provider of the Nations Most Comprehensive Portfolio of Interventional Breast Health Solutions
9. Quest Diagnostics and Hologic Form Strategic Alliance to Improve Womens Health
10. Hologic riceve lapprovazione FDA per una nuova soluzione di mammografia 3D (tomosintesi al seno) a bassa dose per lo screening del tumore al seno
11. Hologic erhält FDA-Zulassung für eine neue niedrigdosierte 3D-Mammographie-Lösung (Brust-Tomosynthese) für Brustkrebs-Screening
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/18/2017)... Research and Markets has announced the addition of the ... ... analytics for the US, Canada , Japan ... Latin America , and Rest of World. Annual estimates ... six-year historic analysis is provided for these markets. Market data and analytics ...
(Date:2/17/2017)... , Feb. 17, 2017 Arvinas LLC, a ... based on protein degradation, today announced the presentation of ... PROTAC during a poster session at the American Society ... in Orlando, FL. ... our platform and the potential of PROTACs to drive ...
(Date:2/17/2017)...   Risperdal lawsuits involving gynecomastia (male breast growth) ... of the atypical antipsychotic medication continue to move forward ... Common Pleas, where the state,s Risperdal docket has been ... notice posted on the Court,s website , the ... 9, 2017 at 11:00 a.m. (In Re: Risperdal Litigation, ...
Breaking Medicine Technology:
(Date:2/20/2017)... PA (PRWEB) , ... February 20, 2017 , ... Researchers ... of thyroid cancer, as well as a marker that may predict response to a ... with many other types of cancer as well. The new findings were published in ...
(Date:2/20/2017)... ... 20, 2017 , ... The StayWell Company and VUCA Health ... patient health risks, foster behavior change and improve health literacy among patients. VUCA Health, ... a demonstration of its video capability at StayWell booth 3443 during HiMSS. , ...
(Date:2/20/2017)... (PRWEB) , ... February 20, 2017 , ... ... technology, welcomes you to stop by for a visit this week at HIMSS ... clinicians and executives from around the globe. Sensogram will be featured in the ...
(Date:2/20/2017)... Sunapee, NH (PRWEB) , ... February 20, 2017 , ... ReportingMD, a Population Health Software ... rapid growth of the company. The new location will triple the size of the ... location for the town of Sunapee, NH. , “We are excited to expand ...
(Date:2/20/2017)... ... February 20, 2017 , ... Johns Hopkins All Children's ... building. A topping out ceremony on Friday marked the halfway point of construction and ... open in Fall 2018, will serve as a center for innovation aimed at finding ...
Breaking Medicine News(10 mins):